Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Statin, antihypertensive treatment don’t guarantee healthier lifestyles

Key clinical point: Despite starting a statin or antihypertensive drug, people can regress on other cardiovascular disease risks factors like body mass and inactivity.

Major finding: Nonobese people starting statin or antihypertensive treatment had a 82% higher incidence of obesity than those not starting these drugs.

Study details: A review of prospectively collected data from 41,225 adults in the Finnish Public Sector Study.

Disclosures: The study received no commercial funding. Dr. Korhonen had no disclosures.


Korhonen MJ et al. J Am Heart Assoc. 2020 Feb 5. doi: 10.1161/JAHA.119.014.168.